Abstract
This study compares the effectiveness of hepatic arterial infusion of mitomycin C with that of 5 fluorouracil in the management of carcinoma of the colon metastatic to the liver. A higher tumor response rate was obtained with 5 FU (10 of 12 patients) than with mitomycin C (6 of 13 patients). The patients treated with mitomycin C had a median survival time of 9.5 mth compared to 12 mth for those receiving 5 FU, but this survival is not much different from that of the untreated historical controls. Femoral artery thrombosis requiring surgical thrombectomy developed in 5 of the 30 catheterized patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 401-404 |
| Number of pages | 4 |
| Journal | CANCER CHEMOTHER.REP. |
| Volume | 59 |
| Issue number | 2 |
| State | Published - Dec 1 1975 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Hepatic arterial infusion for liver metastases from colon cancer: comparison of mitomycin C (NSC 26980) and 5 fluorouracil (NSC 19893)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS